An international effort led by a Stanford Medicine researcher finds more than 50 genes linked to glioma — a rare brain cancer. Although most gliomas are sporadic, a minority are inherited.
Distracting videos ease kids’ radiotherapy
Most children receiving radiation therapy for cancer can hold still without anesthesia if they watch videos during the treatment, a study of a technique developed at Stanford Medicine found.
Antibiotics linked to poorer cancer survival
Triple-negative breast cancer patients who used antibiotics within three years of diagnosis have an increased risk of death, according to a study. The gut microbiome is a likely link.
Skin-colonizing bacteria help fight tumors
In a study led by Stanford Medicine, researchers harnessed the skin’s immune response to bacteria to create an immunotherapy — delivered by swab — that treats aggressive tumors in mice.
DNA circles drive cancer development
Tiny circles of DNA harbor cancer-associated oncogenes and immunomodulatory genes promoting cancer development. They arise during transformation from pre-cancer to cancer, say Stanford Medicine-led team.
Myc-caused sugar changes protect cancers
A novel Stanford School of Medicine partnership uncovers a direct link between a cancer-associated gene, Myc, and sugar patterns on cancer cell surfaces that tell immune cells to stand down.
Cancer cells become cancer cure
Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.
Immune cells become cancer killers
Neutrophils often suppress the immune system’s response to cancer, but when activated, they eliminate several types of tumors in laboratory mice, a study led by Stanford Medicine has found.
Stanford and Invus collaborate
The collaboration will enable the development of medications to treat a type of brain cancer.
Shoshana Levy dies
Shoshana Levy discovered a family of molecules called tetraspanins, launching a new field of cancer research. She was an active researcher, collaborator and mentor at Stanford Medicine for nearly three decades.
Possible new way to kill cancer cells
After finding long, repetitive sequences in the genomes of seven kinds of cancer, researchers at Stanford Medicine and their colleagues developed a molecule that curbed their production.
Hepatitis C treatment low
Antiviral medicine eliminates hepatitis C in 97% of patients, but Stanford Medicine researchers and colleagues find that many don’t receive the treatment.
- Aging & Geriatrics
- AI, Technology & Innovation
- Anesthesiology & Pain Management
- Animal Research
- Autoimmune Conditions
- Blood Disorders (Hematology)
- Cellular & Molecular Biology
- Community Programs
- Data Sciences
- Diversity, Equity & Inclusion
- Drug Development
- Ear, Nose & Throat
- Emergency Medicine
- Environment & Sustainability
- Epidemiology & Population Health
- Global Health
- Health Policy
- Infectious Disease
- Internal Medicine
- Kidney Health (Nephrology)
- Lung Health
- Maternal Health
- Men's Health
- Neurology & Neurosurgery
- Obstetrics & Gynecology
- Palliative Care
- Precision Health
- Preventive Medicine
- Primary Care
- Psychiatry & Mental Health
- Stanford Medicine
- Stem Cells
- Women's Health